And, you know, it was creating the category before it was chic to talk about wearables.

Yeah, no doubt.

Look, I think the early founders of iRhythm saw this opportunity just to improve upon what the standard of care was in the marketplace, to be honest with you.

And I think we embarked upon the early stages of wearable technologies.

I mean, literally, you put a patch on, we like to say you stick it and forget it, but patient puts it on, they wear it for 14 days, and we're capturing just a tremendous amount of insights over the duration of that wear period.

But again, what continues to set us apart and why I think we're unique to the sort of generality of what a wearable is, is that we are at a different level of capability.

We are a true medical grade diagnostic tool that's been approved by the FDA for diagnosis where all these other wearables are not.

Can you talk about the reasoning behind the deal and how it will help enhance iRhythm and also Zio?